Clinical Trials Browser

Phase 1/2 × Neoplasms × Interferon-alpha × Clear all

NCT00277017 2011-09-27

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

Phase 1/2 Completed

Carcinoma, Renal Cell, Neoplasms